Alvotech (ALVO) Change in Inventory (2021 - 2026)
Alvotech's (ALVO) quarterly Change in Inventory came in at -$403000.0 in Q2 2026, up 97.76% on a YoY basis from -$203785.3 in Q2 2025, and up 96.34% quarter-over-quarter from -$11.0 million in Q1 2026.
Analysis
Alvotech (ALVO) Change in Inventory (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Change in Inventory for 6 consecutive years, with -$403000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Inventory rose 97.76% year-over-year to -$403000.0; the trailing twelve-month figure through Jun 2026 stood at -$68.7 million (up 40.07% YoY), and the FY2025 full-year result was -$90.1 million, down 80.36% from the prior year.
- Change in Inventory grew to -$403000.0 in Q2 2026 per ALVO's latest filing, from -$11.0 million in the prior quarter.
- Across five years, Change in Inventory topped out at -$403000.0 in Q2 2026 and bottomed at -$53.0 million in Q3 2025.
- Historically, Change in Inventory has averaged -$18.0 million across 5 years, with a median of -$11.9 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Change in Inventory slumped 546.1% in 2025, then soared 97.76% in 2026.
- Over 5 years, Change in Inventory stood at -$32.4 million in 2022, then surged by 65.12% to -$11.3 million in 2023, then plunged by 342.08% to -$50.0 million in 2024, then soared by 91.48% to -$4.3 million in 2025, then jumped by 90.54% to -$403000.0 in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered -$403000.0, -$11.0 million, and -$4.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -59.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 99.50 Mn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -76.69 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 69.19 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 22.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -403,000.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -305,000.00 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 9.88 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -403,000.00 |
| Mar 31, 2026 | -11.02 Mn |
| Dec 31, 2025 | -4.26 Mn |
| Sep 30, 2025 | -53.03 Mn |
| Jun 30, 2025 | -17.97 Mn |
| Mar 31, 2025 | -14.87 Mn |
| Dec 31, 2024 | -49.97 Mn |
| Sep 30, 2024 | -31.85 Mn |
| Jun 30, 2024 | -2.78 Mn |
| Mar 31, 2024 | -12.42 Mn |
| Dec 31, 2023 | -11.30 Mn |
| Jun 30, 2023 | -4.13 Mn |
| Dec 31, 2022 | -32.41 Mn |
| Jun 30, 2022 | -4.91 Mn |
| Dec 31, 2021 | -17.42 Mn |
| Sep 30, 2021 | -1.72 Mn |